Neurotransmitters, neuropeptides and their receptors interact with immune response in healthy and psoriatic skin

Neuropeptides. 2020 Feb:79:102004. doi: 10.1016/j.npep.2019.102004. Epub 2019 Dec 25.

Abstract

Psoriasis is a chronic inflammatory disease with a multifactorial origin that affects the skin. It is characterized by keratinocyte hyperproliferation, which results in erythemato-squamous plaques. Just as the immune system plays a fundamental role in psoriasis physiopathology, the nervous system maintains the inflammatory process through the neuropeptides and neurotransmitters synthesis, as histamine, serotonin, calcitonin gene-related peptide, nerve growth factor, vasoactive intestinal peptide, substance P, adenosine, glucagon-like peptide, somatostatin and pituitary adenylate cyclase polypeptide. In patients with psoriasis, the systemic or in situ expression of these chemical mediators and their receptors are altered, which affects the clinical activity of patients due to its link to the immune system, provoking neurogenic inflammation. It is important to establish the role of the nervous system since it could represent a therapeutic alternative for psoriasis patients. The aim of this review is to offer a detailed review of the current literature about the neuropeptides and neurotransmitters involved in the physiopathology of psoriasis.

Keywords: Chemical mediators; Immune cells; Neurogenic inflammation; Neuropeptides; Neurotransmitters; Psoriasis.

Publication types

  • Review

MeSH terms

  • Animals
  • Calcitonin Gene-Related Peptide / metabolism
  • Humans
  • Neurogenic Inflammation / metabolism
  • Neuropeptides / metabolism*
  • Neurotransmitter Agents / metabolism*
  • Skin / immunology*
  • Skin / metabolism
  • Vasoactive Intestinal Peptide / metabolism*

Substances

  • Neuropeptides
  • Neurotransmitter Agents
  • Vasoactive Intestinal Peptide
  • Calcitonin Gene-Related Peptide